European Enhanced Recovery After Surgery (ERAS) gynecologic oncology survey: Status of ERAS protocol implementation across Europe

Int J Gynaecol Obstet. 2023 Jan;160(1):306-312. doi: 10.1002/ijgo.14386. Epub 2022 Aug 20.

Abstract

Objective: To acquire a comprehensive assessment of the current status of implementation of Enhanced Recovery After Surgery (ERAS) protocols across Europe.

Methods: The survey was launched by The European Network of Young Gynecologic Oncologists (ENYGO). A 45-item survey was disseminated online through the European Society of Gynecological Oncology (ESGO) Network database.

Results: A total of 116 ESGO centers participated in the survey between December 2020 and June 2021. Overall, 80 (70%) centers reported that ERAS was implemented at their institution: 63% reported a length of stay (LOS) for advanced ovarian cancer surgery between 5 and 7 days; 57 (81%) centers reported a LOS between 2 and 4 days in patients who underwent an early-stage gynecologic cancer surgery. The ERAS items with high reported compliance (>75% "normally-always") included deep vein thrombosis prophylaxis (89%), antibiotic prophylaxis (79%), prevention of hypothermia (55%), and early mobilization (55%). The ERAS items that were poorly adhered to (less than 50%) included early removal of urinary catheter (33%), and avoidance of drains (25%).

Conclusion: This survey shows broad implementation of ERAS protocols across Europe; however, a wide variation in adherence to the various ERAS protocol items was reported.

Keywords: compliance; enhanced recovery after surgery (ERAS); fast-track; gynecologic cancer; ovarian cancer; perioperative care; survey.

MeSH terms

  • Enhanced Recovery After Surgery*
  • Europe
  • Female
  • Genital Neoplasms, Female* / surgery
  • Humans
  • Length of Stay
  • Postoperative Complications / epidemiology
  • Postoperative Complications / prevention & control